Skip to main content
. 2015 Mar 25;2015(3):CD009515. doi: 10.1002/14651858.CD009515.pub2

Comparison 2. LCOS.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 LCOS 4 286 Risk Ratio (M‐H, Random, 95% CI) 0.60 [0.33, 1.09]
1.1 Levosimendan 2 59 Risk Ratio (M‐H, Random, 95% CI) 1.22 [0.32, 4.65]
1.2 Placebo 2 227 Risk Ratio (M‐H, Random, 95% CI) 0.52 [0.28, 0.96]